Literature DB >> 20564534

Intestinal ferroportin expression in pediatric Crohn's disease.

Tyler Burpee1, Paul Mitchell, Douglas Fishman, Shabana Islam, Elizabeta Nemeth, Mark Westerman, Marianne Wessling-Resnick, Richard J Grand.   

Abstract

BACKGROUND: Anemia is a frequent complication of Crohn's disease (CD). The intestinal iron exporter ferroportin (FPN) is involved in both iron deficiency anemia and the anemia of chronic disease. To examine its role in CD, intestinal FPN expression was studied in subjects with and without CD.
METHODS: Duodenal mucosal biopsies from 29 pediatric subjects with CD (n=19) and without CD (n=10) were obtained. FPN protein was measured using Western blot analysis and mRNA was assessed using quantitative real-time polymerase chain reaction (PCR).
RESULTS: Intestinal FPN protein was higher in anemic CD subjects than in nonanemic CD subjects (P=0.01), while FPN mRNA levels were not different (P=0.66). In nonanemic CD subjects, erythrocyte sedimentation rate (ESR) (P=0.04), C-reactive protein (CRP) (P=0.03), and interleukin-6 (IL-6) (P=0.01) levels were elevated compared to controls. Nonanemic CD subjects had a lower median FPN protein than nonanemic controls, although it did not reach statistical significance (P=0.07). Median FPN mRNA was similar between groups (P=0.71). Although no correlation between FPN protein and IL-6 was noted, there was a strong negative correlation between serum iron and IL-6, both in subjects with CD (r=-0.88, P<0.0001) and those without anemia (r=-0.58, P=0.02).
CONCLUSIONS: Intestinal FPN protein is upregulated in anemic CD subjects, suggesting that iron deficiency or anemia is the driving force regulating FPN levels. A transporter distinct from FPN appears to be involved in the hypoferremia associated with the inflammatory process of CD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20564534      PMCID: PMC3733087          DOI: 10.1002/ibd.21367

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  47 in total

1.  Clinical manifestations of Crohn's disease in children and adolescents.

Authors:  E J Burbige; S H Huang; T M Bayless
Journal:  Pediatrics       Date:  1975-06       Impact factor: 7.124

2.  Treatment with iron increases weight gain and psychomotor development.

Authors:  M A Aukett; Y A Parks; P H Scott; B A Wharton
Journal:  Arch Dis Child       Date:  1986-09       Impact factor: 3.791

3.  Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial.

Authors:  C Gasché; C Dejaco; T Waldhoer; W Tillinger; W Reinisch; G F Fueger; A Gangl; H Lochs
Journal:  Ann Intern Med       Date:  1997-05-15       Impact factor: 25.391

4.  Behavior of infants with iron-deficiency anemia.

Authors:  B Lozoff; N K Klein; E C Nelson; D K McClish; M Manuel; M E Chacon
Journal:  Child Dev       Date:  1998-02

Review 5.  Inflammatory bowel disease in pediatric and adolescent patients.

Authors:  R N Baldassano; D A Piccoli
Journal:  Gastroenterol Clin North Am       Date:  1999-06       Impact factor: 3.806

6.  Combined deficiency of iron and vitamin D in Asian toddlers.

Authors:  H Grindulis; P H Scott; N R Belton; B A Wharton
Journal:  Arch Dis Child       Date:  1986-09       Impact factor: 3.791

7.  Effect of iron therapy on behavior performance in nonanemic, iron-deficient infants.

Authors:  F A Oski; A S Honig; B Helu; P Howanitz
Journal:  Pediatrics       Date:  1983-06       Impact factor: 7.124

8.  Treatment of anaemia in inflammatory bowel disease with iron sucrose.

Authors:  G Bodemar; S Kechagias; S Almer; B G Danielson
Journal:  Scand J Gastroenterol       Date:  2004-05       Impact factor: 2.423

9.  Effect of mild iron deficiency on infant mental development scores.

Authors:  T Walter; J Kovalskys; A Stekel
Journal:  J Pediatr       Date:  1983-04       Impact factor: 4.406

10.  Iron deficiency anemia and iron therapy effects on infant developmental test performance.

Authors:  B Lozoff; G M Brittenham; A W Wolf; D K McClish; P M Kuhnert; E Jimenez; R Jimenez; L A Mora; I Gomez; D Krauskoph
Journal:  Pediatrics       Date:  1987-06       Impact factor: 7.124

View more
  2 in total

1.  β-Carotene can reverse dysregulation of iron protein in an in vitro model of inflammation.

Authors:  Oksana Katz; Ram Reifen; Aaron Lerner
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

2.  Serum citrulline as a biomarker of gastrointestinal function during hematopoietic cell transplantation in children.

Authors:  Kerri B Gosselin; Henry A Feldman; Andrew L Sonis; Lori J Bechard; Mark D Kellogg; Kathleen Gura; Robert Venick; Catherine M Gordon; Eva C Guinan; Christopher Duggan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-06       Impact factor: 2.839

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.